SCHEMBL5508740

SCHEMBL5508740

CCOc1ccnc2ccc(C/C=C3\SC(NCc4ccc(F)cc4Cl)=NC3=O)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CISD1 Q9NZ45 1/20 0.36
SLC2A1 P11166 1/20 0.35
BRD4 O60885 1/20 0.33
P2RX7 Q99572 3/20 0.32
PDPK1 O15530 2/20 0.32
ARNT P27540 1/20 0.32
EPAS1 Q99814 1/20 0.32
EGFR P00533 2/20 0.32
ERBB2 P04626 2/20 0.32
GAA P10253 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
APP P05067 1/20 0.31
IDO1 P14902 2/20 0.31
CSF1R P07333 1/20 0.31
PDGFRB P09619 1/20 0.31
KDR P35968 1/20 0.31
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505196 0.90 SLC2A1 (0.36) CISD1SLC2A1PDPK1GAAMEN1
SCHEMBL14437286 0.87 CISD1 (0.45) CISD1SLC2A1BRD4ARNTEPAS1
SCHEMBL5508501 0.83 ABL1 (0.33) CISD1PDPK1APPCYP3A4
SCHEMBL5502564 0.81 CLK4 (0.38) PDPK1MEN1LMNAMAPTKMT2A
SCHEMBL5507005 0.80 CLK1 (0.34) BRD4PDPK1MEN1LMNAMAPT
SCHEMBL5505783 0.80 CYP1A2 (0.34) PDPK1MEN1LMNAKMT2ACYP3A4
SCHEMBL5502774 0.78 HTT (0.35) PDPK1GAAMEN1MAPTKMT2A
SCHEMBL14437272 0.77 CISD1 (0.41) CISD1SLC2A1GAAMEN1LMNA
SCHEMBL5503592 0.74 CLK4 (0.42) EGFRMEN1LMNAMAPTKMT2A
SCHEMBL5510707 0.73 KDM1A (0.37) PDPK1EGFRAPPKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253285-B2 Thiazolinone 4-monosubstituted quinolines HOFFMANN-LA ROCHE INC. (US) 2007-08-07 US disclosed
EP-1797085-A1 THIAZOLINONE 4-MONOSUBSTITUTED QUINOLINES F. Hoffmann-Roche AG (CH) 2007-06-20 EP disclosed
US-20060063805-A1 Thiazolinone 4-monosubstituted quinolines CHEN LI 2006-03-23 US disclosed
WO-2006029861-A1 THIAZOLINONE 4-MONOSUBSTITUTED QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063805-A1 Thiazolinone 4-monosubstituted quinolines CDK1, CDK14, CDK17 CISD1 905/4885SLC2A1 4295/4885BRD4 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.